Pfizer

Pharma Company Pfizer to Partner With Government on Drug Resistance

The Wire Staff 15/02/2019

In a questionable move, the Indian government has tied...

big-pharmarupee-notes-reuters

Big Pharma Firms May Have ‘Underpaid’ Rs 530 Crore in Indian Taxes: New Report

The Wire Staff 19/09/2018

The companies studied are Pfizer, Merck, Johnson & Johnson...

Xtandi carousel

US Students Urge UCLA to Drop Proxy Patent Battle for Cancer Drug in India

Anoo Bhuyan 29/03/2018

The university has been pursuing the battle on behalf...

medicines-reuters-1

Delhi’s RCEP Talks on Intellectual Property Shouldn’t Forget India’s Role as ‘Pharmacy of the World’

Leena Menghaney 05/02/2018

India must resist pressure and make sure the deal...

A recent report published by Medicins sans Frontieres (MSF) suggests that new generation of vaccines are prone to high concentration of patent evergreening. Credit: Pan America Health Organisation/Flickr CC BY-ND 2.0

WIPO Report Downplays Patent Barriers to Vaccine Access

HU Yuanqiong 14/11/2017

As a traditional public health intervention, vaccines have been...

Xtandi carousel

How the University of California Is Fighting Proxy Patent Battle for Expensive Cancer Drug in India

Anoo Bhuyan 17/10/2017

The university appears to be representing pharmaceutical companies Pfizer,...

With Pneumococcal Vaccine Patent, Pfizer Wins on Many Counts

Jacob Puliyel 25/08/2017

Not only was Pfizer given a subsidy to 'develop'...